Initial research demonstrate that this peptide – a dual activator of GLP-1 and glucose-dependent insulinotropic polypeptide receptors – presents a significant breakthrough in weight loss programs . Unlike existing treatments , this dual-action compound shows to modify hunger and energy utilization through multiple pathways . Although more copy